Keywords
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration autour de Joseph Jankovic - Curation (Istex)

Index « Keywords » - entrée « dopamine agonists »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
dopamine agonist < dopamine agonists < dopamine dysregulation syndrome  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000033 (2008) A Schapira [Royaume-Uni]Progress in neuroprotection in Parkinson’s disease
000123 (2011) Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche]Milestones in Parkinson's disease therapeutics
000231 (2008) Peter Jenner [Royaume-Uni]Preventing and controlling dyskinesia in Parkinson's disease—A view of current knowledge and future opportunities
000304 (2007) Anthony Schapira [Royaume-Uni]Future directions in the treatment of Parkinson's disease
000308 (2003) Birgit Högl [Autriche] ; Klaus Seppi [Autriche] ; Elisabeth Brandauer [Autriche] ; Susanne Glatzl [Autriche] ; Birgit Frauscher [Autriche] ; Ulrike Niedermüller [Autriche] ; Gregor Wenning [Autriche] ; Werner Poewe [Autriche]Increased daytime sleepiness in Parkinson's disease: A questionnaire survey
000328 (2011) Atbin Djamshidian [Royaume-Uni] ; Francisco Cardoso [Brésil] ; Donald Grosset [Royaume-Uni] ; Henrietta Bowden [Royaume-Uni] ; Andrew Lees [Royaume-Uni]Pathological gambling in Parkinson's disease—a review of the literature
000440 (2011) Susan Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher Goetz [États-Unis] ; Cristina Sampaio [Portugal]The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
000471 (2007) Charlene Snyder [États-Unis] ; Charles Adler [États-Unis]The patient with Parkinson’s disease: Part I–Treating the motor symptoms;Part II–Treating the nonmotor symptoms
000494 (2008) Shen Lim [Canada] ; Andrew Evans [Australie] ; Janis Miyasaki [Canada]Impulse Control and Related Disorders in Parkinson's Disease
000565 (2008) Fabrizio Stocchi [Italie] ; Michele Tagliati [États-Unis] ; C Olanow [États-Unis]Treatment of levodopa‐induced motor complications
000704 (2003) Matthew Brodsky [États-Unis] ; James Godbold [États-Unis] ; Tom Roth [États-Unis] ; C Olanow [États-Unis]Sleepiness in Parkinson's disease: A controlled study
000714 (2010) Sean O [Royaume-Uni] ; Andrew Evans [Australie] ; Niall Quinn [Royaume-Uni] ; Andrew Lawrence [Royaume-Uni] ; Andrew Lees [Royaume-Uni]Reckless generosity in Parkinson's disease
000760 (2011) Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez [France] ; Susan Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher Goetz [États-Unis] ; Cristina Sampaio [Portugal]The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
000834 (2003) Sebastian Paus [Allemagne] ; Hans Brecht [Allemagne] ; Jürgen Köster [Allemagne] ; Gert Seeger [Allemagne] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne]Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease
000955 (2009) Frank Andersohn [Allemagne] ; Edeltraut Garbe [Allemagne]Cardiac and noncardiac fibrotic reactions caused by ergot‐and nonergot‐derived dopamine agonists
000F79 (2010) Sean O [Royaume-Uni] ; Atbin Djamshidian [Royaume-Uni, Autriche] ; Zeshan Ahmed [Royaume-Uni] ; Andrew Evans [Australie] ; Andrew Lawrence [Royaume-Uni] ; Janice Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees [Royaume-Uni]Impulsive‐compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy
001212 (2004) Katherine Grosset [Royaume-Uni] ; Fiona Needleman [Royaume-Uni] ; Graeme Macphee [Royaume-Uni] ; Donald Grosset [Royaume-Uni]Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five‐drug dose conversion table
001578 (2004) G. Gille [Allemagne] ; S Hung [Allemagne] ; H. Reichmann [Autriche] ; W Rausch [Autriche]Oxidative Stress to Dopaminergic Neurons as Models of Parkinson's Disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/KwdEn.i -k "dopamine agonists" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/KwdEn.i  \
                -Sk "dopamine agonists" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    JankovicV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    dopamine agonists
}}
Wicri

This area was generated with Dilib version V0.6.19.
Data generation: Wed Feb 10 22:03:07 2016. Site generation: Tue Feb 13 16:14:27 2024